We are pleased to announce that Prof. Dr. Jiankang Liu has been appointed Associate Editor of Antioxidants (ISSN 2076-3921, IF 6.313).
Prof. Dr. Jiankang Liu received his B.Sc. from Xi’an Jiaotong Unversity and his Ph.D. in medical science from the Okayama University School of Medicine, Japan. He completed his post-doctoral training in the laboratory of Dr. Bruce Ames at the University of California, Berkeley, and worked as part of the faculty at the University of California at Berkeley, the Children Hospital Oakland Research Institute, the University of California at Irvine, the University of Kentucky College of Medicine, and the Shanghai Institute for Nutritional Science, Chinese Academy of Sciences. Currently, he is a Professor at the University of Health and Rehabilitation Sciences at Qingdao and Xi’an Jiaotong University in Xi’an, China. Prof Dr. Liu’s research interests include molecular and cellular mechanisms of aging, stress, and age-associated diseases, with a focus on redox signaling and mitochondrial metabolism. He has published more than 250 papers （H-index 72） and was elected as one of the most-cited Chinese researchers in the area of Biochemistry, Genetics and Molecular Biology by Elsevier every year from 2014 to 2021, and is in the top 1.5% of the world’s scientists.
The following is a short Q&A with Prof. Dr. Jiankang Liu, who shared his vision for the journal with us as well as his views on the research area:
1. What appealed to you about the journal that made you want to take the role as its Associate Editor?
Antioxidants is one of the four top journals (Redox Biology, Antioxidants and Redox Signaling, Free Radical Biology and Medicine, and Antioxidants) in the area of redox biology, and it is also highly efficient in manuscript processing and paper publishing.
2. What is your vision for Antioxidants?
I believe that Antioxidants has great potential to be more successful as a leading SCI journal in life sciences in the near future.
3. What does the future of this field of research look like?
The field of redox biology will attract more excellent scientists, and the findings in this field will play more and more important roles in life sciences, especially in the areas of aging and age-associated diseases.
4. What do you think of the development of open access in the publishing field?
Open access is the trend and the future of publishing field. No question!
We warmly welcome Prof. Dr. Jiankang Liu in taking up his role as Associate Editor, and we look forward to his leadership, which will help Antioxidants to achieve many milestones.
